Simplex Trading
UBIO

Simplex Trading’s Proshares UltraPro NASDAQ Biotechnology UBIO Stock Holding History

Simplex Trading’s Portfolio UBIO Stock Details UBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-784
Closed -$13K – 8846
2020
Q1 		$13K Buy
+784
New +$22.1K ﹤0.01% 6325
2019
Q2 		– Sell
-315
Closed -$9K – 8231
2019
Q1 		$9K Buy
315
+180
+133% +$5.11K ﹤0.01% 6247
2018
Q4 		$2K Buy
+135
New +$3.82K ﹤0.01% 6669
2017
Q3 		– Sell
-1,552
Closed -$49K – 7028
2017
Q2 		$49K Buy
+1,552
New +$43.6K ﹤0.01% 2422
2016
Q4 		– Sell
-637
Closed -$18K – 6868
2016
Q3 		$18K Buy
+637
New +$18.1K ﹤0.01% 3099
2016
Q2 		– Sell
-97
Closed -$2K – 6755
2016
Q1 		$2K Buy
+97
New +$2.67K ﹤0.01% 4884

Simplex Trading's UBIO Position: Q2 2020 in Review

Simplex Trading sold out of Proshares UltraPro NASDAQ Biotechnology (UBIO) in Q2 2020, closing a stake of 784 shares — an estimated $13K sold.

Simplex Trading first reported a position in UBIO in Q1 2016 and held it in 6 quarters. The position peaked at $49K in Q2 2017. 0 funds tracked by Wall St. Rank hold UBIO as of Q2 2020.

  • Simplex Trading reported no remaining Proshares UltraPro NASDAQ Biotechnology position as of Q2 2020 after selling out during the quarter.
  • Simplex Trading sold 784 Proshares UltraPro NASDAQ Biotechnology shares in Q2 2020, an estimated $13K.
  • Simplex Trading first reported a position in Proshares UltraPro NASDAQ Biotechnology in Q1 2016 and held it in 6 quarters.
  • Simplex Trading's Proshares UltraPro NASDAQ Biotechnology position peaked at $49K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Proshares UltraPro NASDAQ Biotechnology as of Q2 2020.

Based on Simplex Trading's 13F filing for Q2 2020, filed 13 Jul 2020.